English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Sanofi Us
Press release submission
| May 8, 2018
SANOFI US: Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients
Carol Ostrow
| Oct 7, 2017
Dupixent gains approval as atopic dermatitis treatment in Europe
Nicholas Gueguen
| Jul 23, 2017
Study: Dupixent used with topical corticosteroids improves atopic dermatitis
Nicholas Gueguen
| Jul 1, 2017
FDA OKs Kevzara for moderate to severe rheumatoid arthritis
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
Robert Hadley
| Apr 15, 2017
Toujeo maker touts drug’s ability to lower blood sugar
Erianne Leatherman
| Apr 5, 2017
Sanofi Genzyme expands Multiple Myeloma Journey Partners program
Ruth de Jauregui
| Apr 2, 2017
FDA approves Dupixent for atopic dermatitis
Trending
+
Pharmaceuticals
Patient Daily
| Jul 22, 2025
Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
+
Pharmaceuticals
Patient Daily
| Jul 21, 2025
Executive director of COA on 340B abuse: ‘Imagine using cancer patients as a source of revenue’
Patient Daily
| Jul 15, 2025
Gulf Coast Breathe Free Sinus & Allergy Centers earns 250+ Google reviews with a 4.9-star rating
+
Pharmaceuticals
Patient Daily
| Jul 16, 2025
Baylor College confirms success of portable organ care system for lung transplants